Phase I trial of a first-in-class ATR inhibitor VX-970 as monotherapy (mono) or in combination (combo) with carboplatin (CP) incorporating pharmacodynamics (PD) studies.
暂无分享，去创建一个
N. Tunariu | Juanita Lopez | U. Banerji | T. Yap | J. Pollard | S. Carreira | J. Bono | D. Papadatos-Pastos | D. Papadatos-Pastos | M. J. De Miguel Luken | I. Figueiredo | R. Riisnaes | B. Hare | S. Fields | B. O’Carrigan | K. McDermott | R. Lopez | M. Penney | Fang Yang | Raquel Perez Lopez | M. J. D. M. Luken | Jessica Brown | Mahesha Ganegoda | B. O'Carrigan | Jack Pollard | J. D. de Bono | S Z Fields